Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

Articles published in
Am J Kidney Dis
    December 2023
  1. NUNEZ M, Gardner J, Syed S, Webber A, et al
    Diabetes Insipidus in Deceased Donors and Outcomes in Kidney Transplant Recipients.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)00999.
    >> Share

  2. MOTTL AK, Nicholas SB
    KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD.
    Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883.
    >> Share

    October 2023
  3. MCCOY RG, O'Connor PJ
    Insulin Management in Patients With Diabetes Receiving Hemodialysis: Unanswered Questions and Way Forward.
    Am J Kidney Dis. 2023 Oct 30:S0272-6386(23)00857.
    >> Share

    September 2023
  4. TANG M, Kalim S
    Long-term Glycemic Variability: A Variable Glycemic Metric Entangled With Glycated Hemoglobin.
    Am J Kidney Dis. 2023;82:254-256.
    >> Share

  5. DE ROOIJ ENM, de Fijter JW, Le Cessie S, Hoorn EJ, et al
    Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    Am J Kidney Dis. 2023;82:257-266.
    >> Share

    August 2023
  6. EBERT T, SattarMD N, Greig M, Lamina C, et al
    Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia.
    Am J Kidney Dis. 2023 Aug 30:S0272-6386(23)00775.
    >> Share

    July 2023
  7. ALBAKR RB, Sridhar VS, Cherney DZI
    Novel Therapies in Diabetic Kidney Disease and Risk of Hyperkalemia: A Review of the Evidence From Clinical Trials.
    Am J Kidney Dis. 2023 Jul 28:S0272-6386(23)00743.
    >> Share

  8. MORTON JI, Carstensen B, McDonald SP, Polkinghorne KR, et al
    Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Am J Kidney Dis. 2023 Jul 22:S0272-6386(23)00730.
    >> Share

  9. YI TW, Smyth B, Di Tanna GL, Arnott C, et al
    Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
    Am J Kidney Dis. 2023;82:84-96.
    >> Share

  10. GREGG LP, Ramsey DJ, Akeroyd JM, Jafry SA, et al
    Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD.
    Am J Kidney Dis. 2023;82:53-62.
    >> Share

    May 2023
  11. XU Y, Dong S, Fu EL, Sjolander A, et al
    Long-term Visit-to-Visit Variability in Hemoglobin A(1c) and Kidney-Related Outcomes in Persons With Diabetes.
    Am J Kidney Dis. 2023 May 12:S0272-6386(23)00628.
    >> Share

    March 2023
  12. KWON S, Kim YC, Kwon H, Cho JH, et al
    Metformin Use and Long-term Clinical Outcomes in Kidney Transplant Recipients.
    Am J Kidney Dis. 2023 Mar 23:S0272-6386(23)00578.
    >> Share

    February 2023
  13. LUNYERA J, Clare RM, Chiswell K, Scialla JJ, et al
    Association of Acute Kidney Injury and Cardiovascular Disease Following Percutaneous Coronary Intervention: Assessment of Interactions by Race, Diabetes, and Kidney Function.
    Am J Kidney Dis. 2023 Feb 21:S0272-6386(23)00533.
    >> Share

  14. MUSHAILOV V, Horowitz G, Dad T
    Low Serum Bicarbonate in a Patient With Diabetes Mellitus:: A Quiz.
    Am J Kidney Dis. 2023;81:A14-A16.
    >> Share

    December 2022
  15. WATSON KE, Dhaliwal K, Robertshaw S, Verdin N, et al
    Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process.
    Am J Kidney Dis. 2022 Dec 2:S0272-6386(22)01054.
    >> Share

  16. FRIEDMAN AN, Schauer PR, Beddhu S, Kramer H, et al
    Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society.
    Am J Kidney Dis. 2022;80:783-793.
    >> Share

    November 2022
  17. WALTHER CP, Benoit JS, Bansal N, Nambi V, et al
    Heart Failure-Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Am J Kidney Dis. 2022 Nov 17:S0272-6386(22)01041.
    >> Share

  18. EPSTEIN M, Kovesdy CP, Clase CM, Sood MM, et al
    Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms.
    Am J Kidney Dis. 2022;80:658-666.
    >> Share

    October 2022
  19. TUNG S, Kendrick J, Surapaneni A, Scheppach JB, et al
    Association Between Acute Kidney Injury and Dementia in the Atherosclerosis Risk in Communities (ARIC) Study.
    Am J Kidney Dis. 2022;80:495-501.
    >> Share

    September 2022
  20. NAIK AS, Brosius FC
    Cannabinoid Signaling in the Diabetic Proximal Tubule: Of Mice and Men.
    Am J Kidney Dis. 2022 Sep 17. pii: S0272-6386(22)00912.
    >> Share

  21. GARG G, Tedla YG, Ghosh AS, Mohottige D, et al
    Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study.
    Am J Kidney Dis. 2022 Sep 1. pii: S0272-6386(22)00861.
    >> Share

    March 2022
  22. SAPA H, Gutierrez OM, Shlipak MG, Katz R, et al
    Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Am J Kidney Dis. 2022 Mar 26. pii: S0272-6386(22)00577.
    >> Share

    February 2022

  23. Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation.
    Am J Kidney Dis. 2022;79:141-152.
    >> Share

  24. MOTTL AK, Alicic R, Argyropoulos C, Brosius FC, et al
    KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD.
    Am J Kidney Dis. 2022 Feb 1. pii: S0272-6386(21)00924.
    >> Share

    January 2022
  25. KHINE A, Kwok J, Lin E
    Time to Invest in the Future: Assessing the Cost-Effectiveness of Empagliflozin in Diabetic Kidney Disease.
    Am J Kidney Dis. 2022 Jan 31. pii: S0272-6386(21)01012.
    >> Share

  26. JIN Q, Luk AO, Lau ES, Tam CHT, et al
    Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Am J Kidney Dis. 2022 Jan 6. pii: S0272-6386(21)01052.
    >> Share

    November 2021
  27. ZHUO M, Paik JM, Wexler DJ, Bonventre JV, et al
    SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.
    Am J Kidney Dis. 2021 Nov 8. pii: S0272-6386(21)00953.
    >> Share

  28. GUTIERREZ OM, Shlipak MG, Katz R, Waikar SS, et al
    Associations of Plasma Biomarkers of Inflammation, Fibrosis, and Kidney Tubular Injury With Progression of Diabetic Kidney Disease: A Cohort Study.
    Am J Kidney Dis. 2021 Nov 6. pii: S0272-6386(21)00956.
    >> Share

  29. REIFSNIDER OS, Kansal AR, Wanner C, Pfarr E, et al
    Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG Outcome Trial.
    Am J Kidney Dis. 2021 Nov 6. pii: S0272-6386(21)00952.
    >> Share

    October 2021
  30. FENVES AZ, Emmett M
    Approach to Patients With High Anion Gap Metabolic Acidosis: Core Curriculum 2021.
    Am J Kidney Dis. 2021;78:590-600.
    >> Share

    September 2021
  31. HAHR AJ, Molitch ME
    Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
    Am J Kidney Dis. 2021 Sep 29. pii: S0272-6386(21)00762.
    >> Share

  32. LOOKER HC, Lin C, Nair V, Kretzler M, et al
    Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.
    Am J Kidney Dis. 2021 Sep 17. pii: S0272-6386(21)00873.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016